BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18351385)

  • 1. Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients.
    Keslová-Veselíková J; Hůlková H; Dobrovolný R; Asfaw B; Poupetová H; Berná L; Sikora J; Golán L; Ledvinová J; Elleder M
    Virchows Arch; 2008 Jun; 452(6):651-65. PubMed ID: 18351385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease.
    Lee HJ; Park HH; Sohn Y; Ryu J; Park JH; Rhee WJ; Park TH
    Appl Microbiol Biotechnol; 2016 Dec; 100(24):10395-10402. PubMed ID: 27353764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice.
    Higuchi K; Yoshimitsu M; Fan X; Guo X; Rasaiah VI; Yen J; Tei C; Takenaka T; Medin JA
    Mol Med; 2010; 16(5-6):216-21. PubMed ID: 20454522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.
    Porto C; Pisani A; Rosa M; Acampora E; Avolio V; Tuzzi MR; Visciano B; Gagliardo C; Materazzi S; la Marca G; Andria G; Parenti G
    J Inherit Metab Dis; 2012 May; 35(3):513-20. PubMed ID: 22187137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer.
    Ziegler RJ; Yew NS; Li C; Cherry M; Berthelette P; Romanczuk H; Ioannou YA; Zeidner KM; Desnick RJ; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(10):1667-82. PubMed ID: 10428212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa.
    Lin HY; Huang YH; Liao HC; Liu HC; Hsu TR; Shen CI; Li ST; Li CF; Lee LH; Lee PC; Huang CK; Chiang CC; Lin SP; Niu DM
    J Chin Med Assoc; 2014 Apr; 77(4):190-7. PubMed ID: 24388678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].
    Riccio E; Capuano I; Visciano B; Marchetiello C; Petrillo F; Pisani A
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.
    Marchesan D; Cox TM; Deegan PB
    J Inherit Metab Dis; 2012 Nov; 35(6):1107-17. PubMed ID: 22450713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer.
    Choi JO; Lee MH; Park HY; Jung SC
    J Biomed Sci; 2010 Apr; 17(1):26. PubMed ID: 20398385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.
    Ohashi T; Iizuka S; Ida H; Eto Y
    Mol Genet Metab; 2008 Jul; 94(3):313-8. PubMed ID: 18456533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage.
    Wang RY; Abe JT; Cohen AH; Wilcox WR
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S369-74. PubMed ID: 18937048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and Gene Therapy of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
    Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?
    Waldek S; Feriozzi S
    BMC Nephrol; 2014 May; 15():72. PubMed ID: 24886109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease.
    Morel CF; Clarke JT
    Expert Opin Biol Ther; 2009 May; 9(5):631-9. PubMed ID: 19368525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagosome maturation is impaired in Fabry disease.
    Chévrier M; Brakch N; Céline L; Genty D; Ramdani Y; Moll S; Djavaheri-Mergny M; Brasse-Lagnel C; Annie Laquerrière AL; Barbey F; Bekri S
    Autophagy; 2010 Jul; 6(5):589-99. PubMed ID: 20431343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of and recent advances in therapy for Fabry disease.
    Brady RO; Schiffmann R
    JAMA; 2000 Dec; 284(21):2771-5. PubMed ID: 11105184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease.
    Ishii S; Yoshioka H; Mannen K; Kulkarni AB; Fan JQ
    Biochim Biophys Acta; 2004 Nov; 1690(3):250-7. PubMed ID: 15511632
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kytidou K; Beekwilder J; Artola M; van Meel E; Wilbers RHP; Moolenaar GF; Goosen N; Ferraz MJ; Katzy R; Voskamp P; Florea BI; Hokke CH; Overkleeft HS; Schots A; Bosch D; Pannu N; Aerts JMFG
    J Biol Chem; 2018 Jun; 293(26):10042-10058. PubMed ID: 29674318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.
    Wendt S; Whybra C; Kampmann C; Teichmann E; Beck M
    J Inherit Metab Dis; 2005; 28(5):787-8. PubMed ID: 16151910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fabry's disease: a comparison of the effectiveness of two different enzyme replacement therapies].
    Pisani A; Visciano B; Capuano I; Mancini A; Riccio E
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.